These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27751863)

  • 21. Do SNPs in folate pharmacokinetic pathway alter levels of intracellular methotrexate polyglutamates and affect response? A prospective study in Indian patients.
    Sandhu A; Ahmad S; Kaur J; Bhatnagar A; Dhawan V; Dhir V
    Clin Rheumatol; 2018 Dec; 37(12):3221-3228. PubMed ID: 30022368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate.
    Lee YC; Cui J; Costenbader KH; Shadick NA; Weinblatt ME; Karlson EW
    Rheumatology (Oxford); 2009 Jun; 48(6):613-7. PubMed ID: 19193698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ATIC Gene Polymorphism and Histologic Response to Chemotherapy in Pediatric Osteosarcoma.
    Park JA; Shin HY
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):e270-e274. PubMed ID: 28267080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are gene polymorphisms related to adverse events of methotrexate in patients with rheumatoid arthritis? A retrospective cohort study based on an updated meta-analysis.
    Huang J; Fan H; Qiu Q; Liu K; Lv S; Li J; Yang H; Shu X; Xu Y; Lu X; Lu C; Zhang Y; Xiao C
    Ther Adv Chronic Dis; 2020; 11():2040622320916026. PubMed ID: 32426102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients.
    Owen SA; Hider SL; Martin P; Bruce IN; Barton A; Thomson W
    Pharmacogenomics J; 2013 Jun; 13(3):227-34. PubMed ID: 22450926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of MTHFR rs1801133, MTHFR rs1801131 and ABCB1 rs1045642 polymorphisms with increased susceptibility of rheumatoid arthritis in the West Algerian population: A case-control study.
    Boughrara W; Aberkane M; Fodil M; Benzaoui A; Dorgham S; Zemani F; Dahmani C; Petit Teixeira E; Boudjema A
    Acta Reumatol Port; 2015; 40(4):363-71. PubMed ID: 26922200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis.
    Pastore S; Stocco G; Moressa V; Zandonà L; Favretto D; Malusà N; Decorti G; Lepore L; Ventura A
    Rheumatol Int; 2015 Apr; 35(4):619-27. PubMed ID: 25240429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis.
    Plaza-Plaza JC; Aguilera M; Cañadas-Garre M; Chemello C; González-Utrilla A; Faus Dader MJ; Calleja MA
    OMICS; 2012 Nov; 16(11):589-95. PubMed ID: 23095111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High dose methotrexate in adult Egyptian patients with hematological malignancies: impact of ABCB1 3435C > T rs1045642 and MTHFR 677C > T rs1801133 polymorphisms on toxicities and delayed elimination.
    Ebid AIM; Hossam A; El Gammal MM; Soror S; Mangoud NOM; Mahmoud MA
    J Chemother; 2022 Oct; 34(6):381-390. PubMed ID: 34895107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purine biosynthetic pathway genes and methotrexate response in rheumatoid arthritis patients among north Indians.
    Sharma S; Das M; Kumar A; Marwaha V; Shankar S; Singh P; Raghu P; Aneja R; Grover R; Arya V; Dhir V; Gupta R; Kumar U; Juyal RC; K TB
    Pharmacogenet Genomics; 2009 Oct; 19(10):823-8. PubMed ID: 19902562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folyl polyglutamate synthethase (FPGS) gene polymorphisms may influence methotrexate adverse events in South Indian Tamil Rheumatoid Arthritis patients.
    Muralidharan N; Sundaram R; Kodidela S; Chengappa KG; Mariaselvam CM; Misra DP; Negi VS
    Pharmacogenomics J; 2020 Apr; 20(2):342-349. PubMed ID: 31611592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma.
    Linnebank M; Moskau S; Jürgens A; Simon M; Semmler A; Orlopp K; Glasmacher A; Bangard C; Vogt-Schaden M; Urbach H; Schmidt-Wolf IG; Pels H; Schlegel U
    Neuro Oncol; 2009 Feb; 11(1):2-8. PubMed ID: 18806228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphisms predicting methotrexate blood levels and toxicity in adult non-Hodgkin lymphoma.
    Avivi I; Zuckerman T; Krivoy N; Efrati E
    Leuk Lymphoma; 2014 Mar; 55(3):565-70. PubMed ID: 23829278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in folate, pyrimidine, and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasis.
    Campalani E; Arenas M; Marinaki AM; Lewis CM; Barker JN; Smith CH
    J Invest Dermatol; 2007 Aug; 127(8):1860-7. PubMed ID: 17410198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients.
    Moya P; Salazar J; Arranz MJ; Díaz-Torné C; del Río E; Casademont J; Corominas H; Baiget M
    Pharmacogenomics; 2016; 17(1):25-9. PubMed ID: 26652611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population.
    Cáliz R; del Amo J; Balsa A; Blanco F; Silva L; Sanmarti R; Martínez FG; Collado MD; Ramirez Mdel C; Tejedor D; Artieda M; Pascual-Salcedo D; Oreiro N; Andreu JL; Graell E; Simon L; Martínez A; Mulero J
    Scand J Rheumatol; 2012 Feb; 41(1):10-4. PubMed ID: 22044028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.
    Chaabane S; Marzouk S; Akrout R; Ben Hamad M; Achour Y; Rebai A; Keskes L; Fourati H; Bahloul Z; Maalej A
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):385-93. PubMed ID: 26077125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients.
    Soukup T; Dosedel M; Pavek P; Nekvindova J; Barvik I; Bubancova I; Bradna P; Kubena AA; Carazo AF; Veleta T; Vlcek J
    Rheumatol Int; 2015 Jul; 35(7):1149-61. PubMed ID: 25618758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients.
    van der Straaten RJ; Wessels JA; de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Allaart CF; Bogaartz J; Tiller M; Huizinga TW; Guchelaar HJ
    Pharmacogenomics; 2007 Feb; 8(2):141-50. PubMed ID: 17286537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry.
    Salazar J; Garcia-Planella E; Fernández-Clotet A; Esteve M; Gisbert JP; Busquets D; Lucendo A; Márquez L; Guardiola J; Martín-Arranz MD; Iglesias E; Monfort D; Villoria A; Cañete F; Bell O; Ricart E; Zabana Y; Chaparro M; Domènech E; Gordillo J;
    Br J Clin Pharmacol; 2024 May; 90(5):1301-1311. PubMed ID: 38369687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.